Brind.

ABVC BioPharma utilizes in-licensed technology from research institutions, including Cedars-Sinai Medical Center.

2 reports, 1 independent Updated Aug 6
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

ABVC BioPharma utilizes in-licensed technology from research institutions, including Cedars-Sinai Medical Center.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • NewMediaWireABVC BioPharma Gains Confidence From International Investors to Support Growth Path SILICON VALLEY, CA - August 6, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-st
  • Unknown outlet